Traditional drug discovery approaches require docking of molecules into rigid pockets, thus having the ability to bind disordered regions opens up plethora of applications for therapeutic modulation in disease [38], ranging from neurodegenerative diseases (ASYN) [39] through immune system regulation (CD28) [40] to cancer (P53, SUMO) [41]. Here, TP53 is linked to neurodegenerative disease.